Y chromosome probe p49a detects complex PvuII haplotypes and many new TaqI haplotypes in southern African populations.

Por Spurdle, A, Jenkins, T
Publicado em 1992

pDP1007, detects an X polymorphism with HindIII in negroids at the ZFX locus

Por Spurdle, A.B., Jenkins, T.
Publicado em 1990

The origins of the Lemba "Black Jews" of southern Africa: evidence from p12F2 and other Y-chromosome markers.

Por Spurdle, A. B., Jenkins, T.
Publicado em 1996

The Y-associated XY275 low allele is not restricted to indigenous African peoples.

Por Spurdle, A, Ramsay, M, Jenkins, T
Publicado em 1992

New TaqI allele detected by X-chromosome probe S21 (DXS17)

Por Stevens, G., Spurdle, A.B., Jenkins, Trefor
Publicado em 1990

The Y Alu polymorphism in southern African populations and its relationship to other Y-specific polymorphisms.

Por Spurdle, A. B., Hammer, M. F., Jenkins, T.
Publicado em 1994

Referral of Queensland women with endometrial cancer to genetic services

Por Tan, YY, McGaughran, J, Obermair, A, Spurdle, A
Publicado em 2012

Colorectal tumour BRAF V600E and MLH1 promoter methylation status in the assessment of mismatch repair gene sequence variants of unknown clinical significance

Por Parsons, M, Thompson, B, Goldgar, D, Hopper, J, Jenkins, M, Buchanan, D, Young, J, Spurdle, A
Publicado em 2012

Assessing biases of information contained in pedigrees for the classification of BRCA-genetic variants: a study arising from the ENIGMA analytical working group

Por Kerkhofs, C. H. H., Spurdle, A. B., Lindsey, P. J., Goldgar, D. E., Gómez-García, E. B.
Publicado no Hered Cancer Clin Pract (2016)

Localization of the gene causing keratolytic winter erythema to chromosome 8p22-p23, and evidence for a founder effect in South African Afrikaans-speakers.

Por Starfield, M, Hennies, H C, Jung, M, Jenkins, T, Wienker, T, Hull, P, Spurdle, A, Küster, W, Ramsay, M, Reis, A
Publicado em 1997

Low frequency of CHEK2 1100delC allele in Australian multiple-case breast cancer families: functional analysis in heterozygous individuals

Por Jekimovs, C R, Chen, X, Arnold, J, Gatei, M, Richard, D J, Spurdle, A B, Khanna, K K, Chenevix-Trench, G
Publicado em 2005

BRCA1 and BRCA2 genetic testing—pitfalls and recommendations for managing variants of uncertain clinical significance

Por Eccles, D. M., Mitchell, G., Monteiro, A. N. A., Schmutzler, R., Couch, F. J., Spurdle, A. B., Gómez-García, E. B.
Publicado no Ann Oncol (2015)

The Geographic Distribution of Human Y Chromosome Variation

Por Hammer, M. F., Spurdle, A. B., Karafet, T., Bonner, M. R., Wood, E. T., Novelletto, A., Malaspina, P., Mitchell, R. J., Horai, S., Jenkins, T., Zegura, S. L.
Publicado em 1997

Estimation of probabilities in favour of pathogenicity for missense substitutions for use in clinical evaluation of mismatch repair gene variants

Por Thompson, B, Goldgar, D, Paterson, C, Clendenning, M, Walters, R, Arnold, S, Parsons, M, Walsh, M, Hopper, J, Jenkins, M, Greenblatt, M, Buchanan, D, Young, J, Tavtigian, S, Spurdle, A
Publicado em 2012

Genetic, functional, and histopathological evaluation of two C‐terminal BRCA1 missense variants

Por Lovelock, P K, Healey, S, Au, W, Sum, E Y M, Tesoriero, A, Wong, E M, Hinson, S, Brinkworth, R, Bekessy, A, Diez, O, Izatt, L, Solomon, E, Jenkins, M, Renard, H, Hopper, J, Waring, P, Investigators, kConFab, Tavtigian, S V, Goldgar, D, Lindeman, G J, Visvader, J E, Couch, F J, Henderson, B R, Southey, M, Chenevix‐Trench, G, Spurdle, A B, Brown, M A
Publicado em 2006

Identification of a novel prostate cancer susceptibility variant in the KLK3 gene transcript

Por Kote-Jarai, Z., Amin Al Olama, A., Leongamornlert, D., Tymrakiewicz, M., Saunders, E., Guy, M., Giles, G. G., Severi, G., Southey, M., Hopper, J. L., Sit, K. C., Harris, J. M., Batra, J., Spurdle, A. B., Clements, J. A., Hamdy, F., Neal, D., Donovan, J., Muir, K., Pharoah, P. D. P., Chanock, S. J., Brown, N., Benlloch, S., Castro, E., Mahmud, N., O’Brien, L., Hall, A., Sawyer, E., Wilkinson, R., Easton, D. F., Eeles, R. A.
Publicado em 2011

Infertility and incident endometrial cancer risk: a pooled analysis from the epidemiology of endometrial cancer consortium (E2C2)

Por Yang, H P, Cook, L S, Weiderpass, E, Adami, H-O, Anderson, K E, Cai, H, Cerhan, J R, Clendenen, T V, Felix, A S, Friedenreich, C M, Garcia-Closas, M, Goodman, M T, Liang, X, Lissowska, J, Lu, L, Magliocco, A M, McCann, S E, Moysich, K B, Olson, S H, Petruzella, S, Pike, M C, Polidoro, S, Ricceri, F, Risch, H A, Sacerdote, C, Setiawan, V W, Shu, X O, Spurdle, A B, Trabert, B, Webb, P M, Wentzensen, N, Xiang, Y-B, Xu, Y, Yu, H, Zeleniuch-Jacquotte, A, Brinton, L A
Publicado no Br J Cancer (2015)

Validating genetic risk associations for ovarian cancer through the international Ovarian Cancer Association Consortium

Por Pearce, C L, Near, A M, Van Den Berg, D J, Ramus, S J, Gentry-Maharaj, A, Menon, U, Gayther, S A, Anderson, A R, Edlund, C K, Wu, A H, Chen, X, Beesley, J, Webb, P M, Holt, S K, Chen, C, Doherty, J A, Rossing, M A, Whittemore, A S, McGuire, V, DiCioccio, R A, Goodman, M T, Lurie, G, Carney, M E, Wilkens, L R, Ness, R B, Moysich, K B, Edwards, R, Jennison, E, Kjaer, S K, Hogdall, E, Hogdall, C K, Goode, E L, Sellers, T A, Vierkant, R A, Cunningham, J C, Schildkraut, J M, Berchuck, A, Moorman, P G, Iversen, E S, Cramer, D W, Terry, K L, Vitonis, A F, Titus-Ernstoff, L, Song, H, Pharoah, P D P, Spurdle, A B, Anton-Culver, H, Ziogas, A, Brewster, W, Galitovskiy, V, Chenevix-Trench, G
Publicado em 2009

Validating genetic risk associations for ovarian cancer through the International Ovarian Cancer Association Consortium

Por Pearce, C L, Near, A M, Van Den Berg, D J, Ramus, S J, Gentry-Maharaj, A, Menon, U, Gayther, S A, Anderson, A R, Edlund, C K, Wu, A H, Chen, X, Beesley, J, Webb, P M, Holt, S K, Chen, C, Doherty, J A, Rossing, M A, Whittemore, A S, McGuire, V, DiCioccio, R A, Goodman, M T, Lurie, G, Carney, M E, Wilkens, L R, Ness, R B, Moysich, K B, Edwards, R, Jennison, E, Kjaer, S K, Hogdall, E, Hogdall, C K, Goode, E L, Sellers, T A, Vierkant, R A, Cunningham, J M, Schildkraut, J M, Berchuck, A, Moorman, P G, Iversen, E S, Cramer, D W, Terry, K L, Vitonis, A F, Titus-Ernstoff, L, Song, H, Pharoah, P D P, Spurdle, A B, Anton-Culver, H, Ziogas, A, Brewster, W, Galitovskiy, V, Chenevix-Trench, G
Publicado em 2009

The TP53 Arg72Pro and MDM2 309G>T polymorphisms are not associated with breast cancer risk in BRCA1 and BRCA2 mutation carriers

Por Sinilnikova, O M, Antoniou, A C, Simard, J, Healey, S, Léoné, M, Sinnett, D, Spurdle, A B, Beesley, J, Chen, X, Greene, M H, Loud, J T, Lejbkowicz, F, Rennert, G, Dishon, S, Andrulis, I L, Domchek, S M, Nathanson, K L, Manoukian, S, Radice, P, Konstantopoulou, I, Blanco, I, Laborde, A L, Durán, M, Osorio, A, Benitez, J, Hamann, U, Hogervorst, F B L, van Os, T A M, Gille, H J P, Peock, S, Cook, M, Luccarini, C, Evans, D G, Lalloo, F, Eeles, R, Pichert, G, Davidson, R, Cole, T, Cook, J, Paterson, J, Brewer, C, Hughes, D J, Coupier, I, Giraud, S, Coulet, F, Colas, C, Soubrier, F, Rouleau, E, Bièche, I, Lidereau, R, Demange, L, Nogues, C, Lynch, H T, Schmutzler, R K, Versmold, B, Engel, C, Meindl, A, Arnold, N, Sutter, C, Deissler, H, Schaefer, D, Froster, U G, Aittomäki, K, Nevanlinna, H, McGuffog, L, Easton, D F, Chenevix-Trench, G, Stoppa-Lyonnet, D
Publicado em 2009